Myelin oligodendrocyte glycoprotein (MOG) antibodies have been found in a broad range of demyelination diseases. In the present study, we reported three cases of patients with anti-MOG antibodies associated disorders (MOG-ADs) who initially presented as intracranial infection like encephalomeningitis with no evidence of demyelination injury, but were subsequently found the expression of MOG antibodies and other demyelination presentations. Our findings suggested that MOG-ADs can start as an intracranial infection like prodromal symptoms prior to the lesions of optic nerve, spinal cord, and white matter. Therefore, clinicians should be cautious of MOG-ADs in cases of encephalomeningitis even without demyelination injury.
基金:
Flagship Program of Tongji Hospital [2019CR106]; second batch of clinician research projects of HUST
第一作者单位:[1]Huazhong Univ Sci & Technol,Tongji Hosp,Dept Neurol,Tongji Med Coll,1095 Jiefang Ave,Wuhan 430030,Hubei,Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Zhang Han,Yang Yang,Luo Xiang.Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report[J].JOURNAL OF NEUROIMMUNOLOGY.2021,353:doi:10.1016/j.jneuroim.2021.577519.
APA:
Zhang, Han,Yang, Yang&Luo, Xiang.(2021).Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report.JOURNAL OF NEUROIMMUNOLOGY,353,
MLA:
Zhang, Han,et al."Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report".JOURNAL OF NEUROIMMUNOLOGY 353.(2021)